1. Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients with Tardive Dyskinesia. (April 2021) Authors: Wilhelm, Amanda; Anderson, Karen E.; Fernandez, Hubert H.; Barkay, Hadas; Chaijale, Nayla; Send, Alexander F.; Savola, Juha-Matti; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deutetrabenazine Reduces Severe Tardive Dyskinesia Movements in a 3-year Open-Label Extension Trial. (April 2021) Authors: Chaijale, Nayla; Bona, Joseph; Barkay, Hadas; Wilhelm, Amanda; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose Patterns for Long-Term Deutetrabenazine Treatment in Patients With Tardive Dyskinesia by Baseline AIMS Item 8 Score. (April 2022) Authors: Barkay, Hadas; Finkbeiner, Stacy; Wilhelm, Amanda; Alexander, Jessica; Chaijale, Nayla; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia. (April 2021) Authors: Sajatovic, Martha; Wilhelm, Amanda; Finkbeiner, Stacy; Barkay, Hadas; Chaijale, Nayla; Gross, Nicholas; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗